Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance Letter uri icon

Overview

MeSH Major

  • Immunologic Factors
  • Multiple Myeloma
  • Thalidomide

publication date

  • December 2013

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1038/leu.2013.126

PubMed ID

  • 23608883

Additional Document Info

start page

  • 2422

end page

  • 4

volume

  • 27

number

  • 12